HORIZONH2020
Innovation Acta SRL
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 28
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 5,595,766
- Active
- 2017 to 2025
Projects
28 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| HDM-FUNHost directed medicine in invasive fungal infection | H2020 | 2020 | Participant | EUR 350,500 |
| RESHAPEReshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials | H2020 | 2019 | Participant | EUR 426,100 |
| NECESSITYNEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | H2020 | 2019 | Participant | EUR 300,000 |
| RESTORERESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients | H2020 | 2019 | Participant | EUR 587,500 |
| HIPGENPlacenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial | H2020 | 2018 | Participant | EUR 83,225 |
| INTEGRATAIntegrating chemical and biological approaches to target NAD production and signaling in cancer | H2020 | 2018 | Partner | EUR 0 |
| PACEA multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | H2020 | 2017 | Participant | EUR 67,875 |
| LIVERHOPESIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | H2020 | 2017 | Participant | EUR 37,281 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.